Mocking TR, Haaksma LH, Reuvekamp T, Kelder A, et al. Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial. Leukemia 2025 Sep 3. doi: 10.1038/s41375-025-02747.
PMID: 40903492